Updating results

1801 results

Sort: Relevance | Date

Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)

Evidence-based recommendations on culizumab (Soliris) for treating atypical haemolytic uraemic syndrome (aHUS)

Highly specialised technologies guidance Published January 2015

Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (HST3)

Evidence-based recommendations on ataluren (Translarna) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene..

Highly specialised technologies guidance Published July 2016

Elosulfase alfa for treating mucopolysaccharidosis type IVa (HST2)

Evidence-based recommendations on elosulfase alfa (Vimizim) for treating mucopolysaccharidosis type IVa (MPS IVA)

Highly specialised technologies guidance Published December 2015

Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 (CLN2) in children

Highly specialised technologies guidance Published November 2019

Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations (HST11)

Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies (confirmed biallelic RPE65 gene mutations)

Highly specialised technologies guidance Published October 2019

Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)

Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people

Highly specialised technologies guidance Published October 2018

Eliglustat for treating type 1 Gaucher disease (HST5)

Evidence-based recommendations on eliglustat (Cerdelga) for treating type 1 Gaucher disease in adults

Highly specialised technologies guidance Published June 2017

Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)

Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in adults and children

Highly specialised technologies guidance Published August 2017

Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency (HST7)

Evidence-based recommendation on Strimvelis for adenosine deaminase deficiency–severe combined immunodeficiency (ADA–SCID)

Highly specialised technologies guidance Published February 2018

Migalastat for treating Fabry disease (HST4)

Evidence-based recommendations on migalastat (Galafold) for treating Fabry disease in people over 16

Highly specialised technologies guidance Published February 2017

Patisiran for treating hereditary transthyretin amyloidosis (HST10)

Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy

Highly specialised technologies guidance Published August 2019

Inotersen for treating hereditary transthyretin amyloidosis (HST9)

Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

Highly specialised technologies guidance Published May 2019

OTL-200 for treating metachromatic leukodystrophy [ID1666]

Proposed [GID-HST10028] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Velmanase alfa for treating alpha-mannosidosis [ID800]

In development [GID-HST10010] Expected publication date: TBC

Highly specialised technologies guidance In development

Human alpha1-proteinase inhibitor for treating emphysema ID856

In development [GID-HST10017] Expected publication date: TBC

Highly specialised technologies guidance In development

Afamelanotide for treating erythropoietic protoporphyria [ID927]

In development [GID-HST10009] Expected publication date: TBC

Highly specialised technologies guidance In development

Metreleptin for treating lipodystrophy (ID861)

In development [GID-HST10011] Expected publication date: TBC

Highly specialised technologies guidance In development

OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]

Proposed [GID-HST10022] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Ravulizumab for treating paroxysmal nocturnal haemoglobinuria ID1457

Proposed [GID-HST10023] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Proposed [GID-HST10019] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Lysosomal acid lipase deficiency - sebelipase alfa [ID737]

In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC

Highly specialised technologies guidance In development

VTS-270 for treating Niemann-Pick type C1 (ID1267)

Proposed [GID-HST10020] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]

In development [GID-HST10026] Expected publication date: 08 September 2020

Highly specialised technologies guidance In development

Volanesorsen for treating familial chylomicronaemia syndrome [ID1326]

In development [GID-HST10015] Expected publication date: 03 June 2020

Highly specialised technologies guidance In development

Elosulfase alfa for treating mucopolysaccharidosis type IVa (review of HST2) [ID1643]

In development [GID-HST10027] Expected publication date: TBC

Highly specialised technologies guidance In development

Faecal microbiota transplant for recurrent Clostridium difficile infection (IPG485)

Evidence-based recommendations on faecal microbiota (bacteria) transplant for recurrent Clostridium difficile (C. difficile/C. diff) infection

Interventional procedures guidance Published March 2014

Percutaneous endoscopic laser thoracic discectomy (IPG61)

Evidence-based recommendations on percutaneous endoscopic laser thoracic discectomy for treating symptomatic thoracic disc herniation (TDH/disc bulge)

Interventional procedures guidance Published May 2004

Thrombin injections for pseudoaneurysms (IPG60)

Evidence-based recommendations on thrombin injections for treating pseudoaneurysms (false aneurysms)

Interventional procedures guidance Published May 2004

Falloposcopy with coaxial catheter (IPG62)

Evidence-based recommendations on falloposcopy with coaxial catheter for investigating and treating subfertility in women

Interventional procedures guidance Published June 2004

Balloon dilatation of pulmonary valve stenosis (IPG67)

Evidence-based recommendations on balloon dilatation for treating pulmonary valve stenosis (PVS)

Interventional procedures guidance Published June 2004

Artificial anal sphincter implantation (IPG66)

Evidence-based recommendations on artificial anal sphincter implantation for treating faecal incontinence

Interventional procedures guidance Published June 2004

Scleral expansion surgery for presbyopia (IPG70)

Evidence-based recommendations on scleral expansion surgery for presbyopia

Interventional procedures guidance Published July 2004

Balloon dilatation of systemic to pulmonary arterial shunts in children (IPG77)

Evidence-based recommendations on balloon dilatation of systemic to pulmonary arterial shunts for cyanotic congenital heart disease in children

Interventional procedures guidance Published July 2004

Radiofrequency ablation of varicose veins (IPG8)

Evidence-based recommendations on radiofrequency ablation of varicose veins

Interventional procedures guidance Published September 2003

Sacral nerve stimulation for faecal incontinence (IPG99)

Evidence-based recommendations on sacral nerve stimulation for treating faecal incontinence

Interventional procedures guidance Published November 2004

Laparoscopic radical hysterectomy for early stage cervical cancer (IPG338)

Evidence-based recommendations on laparoscopic radical hysterectomy for treating early stage cervical cancer

Interventional procedures guidance Published May 2010

Cyanoacrylate glue occlusion for varicose veins (IPG526)

Evidence-based recommendations on cyanoacrylate glue occlusion for varicose veins

Interventional procedures guidance Published June 2015

Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease (IPG540)

Evidence-based recommendations on electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease (GORD)

Interventional procedures guidance Published December 2015

Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes (IPG534)

Evidence-based recommendations on implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes

Interventional procedures guidance Published November 2015

Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma (IPG539)

Evidence-based recommendations on radiofrequency ablation for symptomatic interdigital (Morton’s) neuroma

Interventional procedures guidance Published December 2015

Insertion of a subretinal prosthesis system for retinitis pigmentosa (IPG537)

Evidence-based recommendations on insertion of a subretinal prosthesis system for retinitis pigmentosa (RP)

Interventional procedures guidance Published December 2015

Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer (IPG532)

Evidence-based recommendations on low energy contact X-ray brachytherapy (the Papillon technique) for treating early stage rectal cancer

Interventional procedures guidance Published September 2015

Transcranial direct current stimulation (tDCS) for depression (IPG530)

Evidence-based recommendations on transcranial direct current stimulation (tDCS) for depression

Interventional procedures guidance Published August 2015

Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section (IPG528)

Evidence-based recommendations on the insertion of a double balloon catheter for inducing labour in pregnant women without previous caesarean section

Interventional procedures guidance Published July 2015

Joint distraction for knee osteoarthritis without alignment correction (IPG529)

Evidence-based recommendations on joint distraction for knee osteoarthritis without alignment correction

Interventional procedures guidance Published July 2015

Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache (IPG527)

Evidence-based recommendations on the implantation of a sphenopalatine ganglion stimulation device for treating chronic cluster headaches

Interventional procedures guidance Published June 2015

Electrotherapy for the treatment of haemorrhoids (IPG525)

Evidence-based recommendations on electrotherapy for treating haemorrhoids

Interventional procedures guidance Published June 2015

Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (IPG552)

Evidence-based recommendations on transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine

Interventional procedures guidance Published March 2016

Percutaneous transforaminal endoscopic lumbar discectomy for sciatica (IPG556)

Evidence-based recommendations on percutaneous transforaminal endoscopic lumbar discectomy for sciatica

Interventional procedures guidance Published April 2016

Endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia (IPG550)

Evidence-based recommendations on endoscopic carbon dioxide laser cricopharyngeal myotomy for relieving oropharyngeal dysphagia (swallowing difficulties)

Interventional procedures guidance Published March 2016